Epigenetic regulation of microRNA expression in renal cell carcinoma

Biochemical and Biophysical Research Communications

Volumn 436, Issue 1, 2013, Pages 79-84

  Schiffgen, Miriam ^a   Schmidt, Doris H ^a   von Rücker, Alexander ^b   Müller, Stefan C ^a   Ellinger, Jörg ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Labor Dr Quade und Kollegen GmbH   (Germany)

Author keywords

DNA methylation; Histone acetylation; MircoRNA; Renal cell carcinoma

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; HISTONE H3; HISTONE H4; MICRORNA; MICRORNA 9; VORINOSTAT;

ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; EPIGENETICS; HISTONE ACETYLATION; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION;

AZACITIDINE; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA METHYLATION; DNA MODIFICATION METHYLASES; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HISTONE DEACETYLASES; HISTONES; HUMANS; HYDROXAMIC ACIDS; KIDNEY NEOPLASMS; MICRORNAS; PROMOTER REGIONS, GENETIC; RNA;

EID: 84879152175     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.061     Document Type: Article

References (32)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
2. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
3. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
4. Volinia S., Calin G.A., Liu C.G., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 2006, 103:2257-2261.
5. Davalos V., Esteller M. MicroRNAs and cancer epigenetics: a macrorevolution. Curr. Opin. Oncol. 2010, 22:35-45.
6. Herman J.G., Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 2003, 349:2042-2054.
7. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
8. Hauptstock V., Kuriakose S., Schmidt D., et al. Glutathione-S-transferase pi 1(GSTP1) gene silencing in prostate cancer cells is reversed by the histone deacetylase inhibitor depsipeptide. Biochem. Biophys. Res. Commun. 2011, 412:606-611.
9. Kawamoto K., Hirata H., Kikuno N., et al. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Int. J. Cancer 2008, 123:535-542.
10. Paiva F., Duarte-Pereira S., Costa V.L., et al. Functional and epigenetic characterization of the KRT19 gene in renal cell neoplasms. DNA Cell Biol. 2011, 30:85-90.
11. Wulfken L.M., Moritz R., Ohlmann C., et al. MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS One 2011, 6:e25787.
12. Wotschofsky Z., Meyer H.A., Jung M., et al. Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases. Anal. Biochem. 2011, 417:233-241.
13. Lujambio A., Calin G.A., Villanueva A., et al. A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl. Acad. Sci. USA 2008, 105:13556-13561.
14. Ellinger J., Bastian P.J., Jurgan T., et al. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer. Urology 2008, 71:161-167.
15. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell 2007, 128:683-692.
16. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10:704-714.
17. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12:861-874.
18. Nalls D., Tang S.N., Rodova M., et al. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. PLoS One 2011, 6:e24099.
19. Chen M.Y., Liao W.S., Lu Z., et al. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy. Cancer 2011, 117:4424-4438.
20. Majid S., Dar A.A., Ahmad A.E., et al. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 2009, 30:662-670.
21. Hirata H., Hinoda Y., Nakajima K., et al. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. Int. J. Cancer 2011, 128:1793-1803.
22. Tavares T.S., Nanus D., Yang X.J., et al. Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment. Cancer Biol. Ther. 2008, 7:1607-1618.
23. Saito Y., Liang G., Egger G., et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006, 9:435-443.
24. Lehmann U., Hasemeier B., Christgen M., et al. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J. Pathol. 2008, 214:17-24.
25. Lujambio A., Ropero S., Ballestar E., et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 2007, 67:1424-1429.
26. Hwang H.W., Mendell J.T. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer 2007, 96(Suppl.):R40-R44.
27. Neal C.S., Michael M.Z., Rawlings L.H., et al. The VHL-dependent regulation of microRNAs in renal cancer. BMC Med 2010, 8:64.
28. Hildebrandt M.A., Gu J., Lin J., et al. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 2010, 29:5724-5728.
29. Tsai K.W., Liao Y.L., Wu C.W., et al. Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics 2011, 6:1189-1197.
30. Mosashvilli D., Kahl P., Mertens C., et al. Global histone acetylation levels: prognostic relevance in patients with renal cell carcinoma. Cancer Sci. 2010, 101:2664-2669.
31. Saito Y., Suzuki H., Taya T., et al. Development of a novel microRNA promoter microarray for ChIP-on-chip assay to identify epigenetically regulated microRNAs. Biochem. Biophys. Res. Commun. 2012.
32. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 2007, 8:286-298.